1. Home
  2. PYPL vs RMD Comparison

PYPL vs RMD Comparison

Compare PYPL & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PayPal Holdings Inc.

PYPL

PayPal Holdings Inc.

HOLD

Current Price

$45.27

Market Cap

41.3B

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$228.09

Market Cap

33.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PYPL
RMD
Founded
1998
1989
Country
United States
United States
Employees
N/A
10600
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.3B
33.6B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
PYPL
RMD
Price
$45.27
$228.09
Analyst Decision
Hold
Buy
Analyst Count
30
10
Target Price
$62.84
$293.20
AVG Volume (30 Days)
14.0M
931.8K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
1.22%
1.05%
EPS Growth
35.59
N/A
EPS
5.41
N/A
Revenue
$33,172,000,000.00
N/A
Revenue This Year
$4.81
$10.64
Revenue Next Year
$4.26
$7.46
P/E Ratio
$8.51
$25.61
Revenue Growth
4.32
N/A
52 Week Low
$38.46
$202.00
52 Week High
$79.50
$293.81

Technical Indicators

Market Signals
Indicator
PYPL
RMD
Relative Strength Index (RSI) 49.49 44.45
Support Level $43.33 $218.39
Resistance Level $46.48 $232.60
Average True Range (ATR) 1.30 5.49
MACD 0.19 1.57
Stochastic Oscillator 59.34 63.03

Price Performance

Historical Comparison
PYPL
RMD

About PYPL PayPal Holdings Inc.

PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 434 million active accounts at the end of 2024. The company also owns Venmo, a person-to-person payment platform.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: